Fractional flow reserve (FFR) and the instantaneous wave-free ratio (iFR) pullback gradients overestimate the benefit of target lesion percutaneous coronary intervention (PCI) and can miss residual ischemia in one-third of patients, according the UK-based SERIAL trial.